352
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment

, , &
Pages 1729-1736 | Published online: 06 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Bidur Banjara, Nabin Poudel, Kimberly B Garza, Salisa Westrick, Heather P Whitley, David Redden & Surachat Ngorsuraches. (2022) Patients’ Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Patient Preference and Adherence 16, pages 3415-3428.
Read now
Yuyu Lv, Ru Ren, Chengxiang Tang, Kuimeng Song, Shunping Li & Haipeng Wang. (2022) Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment. Patient Preference and Adherence 16, pages 2335-2344.
Read now
Sarah Janse, Ellen Janssen, Tanya Huwig, Upal Basu Roy, Andrea Ferris, Carolyn J. Presley & John F. P. Bridges. (2021) Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment. Current Medical Research and Opinion 37:4, pages 643-653.
Read now
Ellen M Janssen, Sydney M Dy, Alexa S Meara, Peter J Kneuertz, Carolyn J Presley & John F P Bridges. (2020) Analysis of Patient Preferences in Lung Cancer – Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects. Patient Preference and Adherence 14, pages 927-937.
Read now

Articles from other publishers (13)

Mu'taman Jarrar, MaiAbdel Haleem Abusalah, Waleed Albaker, Mohammad Al-Bsheish, Adi Alsyouf, Khalid Al-Mugheed, MarwanRasmi Issa & Arwa Alumran. (2023) Prevalence of type 2 diabetes mellitus in the general population of Saudi Arabia, 2000–2020: A systematic review and meta-analysis of observational studies. Saudi Journal of Medicine and Medical Sciences 11:1, pages 1.
Crossref
Akram Ahmad, Muhammad Umair Khan & Parisa Aslani. (2022) Patient preferences for the treatment of type 2 diabetes in Australia: a discrete choice experiment. Journal of Diabetes & Metabolic Disorders 21:1, pages 229-240.
Crossref
Sumudu Karunaratna, Manuj C Weerasinghe, Thushara Ranasinghe, Rohan Jayasuriya, Nadeeka Chandraratne, Hemantha Herath & Matthew Quaife. (2022) Improving uptake of non-communicable disease screening in Sri Lanka: eliciting people’s preferences using a discrete choice experiment. Health Policy and Planning 37:2, pages 218-231.
Crossref
Ilene L. Hollin, Ellen Janssen, Marcella A. Kelley & John F. P. Bridges. (2021) Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis. BMC Medical Informatics and Decision Making 21:1.
Crossref
Rajib Paul, Oluwaseun Adeyemi, Subhanwita Ghosh, Kamana Pokhrel & Ahmed A. Arif. (2021) Dynamics of Covid-19 mortality and social determinants of health: a spatiotemporal analysis of exceedance probabilities. Annals of Epidemiology 62, pages 51-58.
Crossref
Rajib Paul, Ahmed Arif, Kamana Pokhrel & Subhanwita Ghosh. (2021) The Association of Social Determinants of Health With COVID‐19 Mortality in Rural and Urban Counties. The Journal of Rural Health 37:2, pages 278-286.
Crossref
Jana Sommer, Jan Dyczmons, Sandra Grobosch, Veronika Gontscharuk, Markus Vomhof, Michael Roden & Andrea Icks. (2020) Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experiment. BMJ Open 10:9, pages e036995.
Crossref
Aude Roborel de Climens, Emilie Pain, Anders Boss & Alka Shaunik. (2020) Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK. Diabetes Therapy 11:8, pages 1873-1881.
Crossref
Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Jürgen Kübler, Juhaeri Juhaeri, Antonio Ciaglia, Steven Simoens, Hilde Stevens, Meredith Smith, Bennett Levitan, Irina Cleemput, Esther de Bekker-Grob & Jorien Veldwijk. (2019) Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Medical Informatics and Decision Making 19:1.
Crossref
Kristoffer Panduro Madsen, Bryan Cleal, Kasper Olesen, Lise Hagelund & Ingrid Willaing. (2019) Willingness to pay for flexibility at the workplace for people with diabetes and chronic disease: a discrete choice experiment in a population of workers in Denmark. BMC Public Health 19:1.
Crossref
Matthew Reaney, Elizabeth Bush, Mary New, Jean Paty, Aude Roborel de Climens, Soren E. Skovlund, Linda Nelsen, Emuella Flood & Adam Gater. (2019) The Potential Role of Individual-Level Benefit-Risk Assessment in Treatment Decision Making: A DIA Study Endpoints Community Workstream. Therapeutic Innovation & Regulatory Science 53:5, pages 630-638.
Crossref
John F. P. Bridges, Jui-Hua Tsai, Ellen Janssen, Norah L. Crossnohere, Ryan Fischer & Holly Peay. (2018) How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event. The Patient - Patient-Centered Outcomes Research 12:2, pages 247-257.
Crossref
Eline van Overbeeke, Chiara Whichello, Rosanne Janssens, Jorien Veldwijk, Irina Cleemput, Steven Simoens, Juhaeri Juhaeri, Bennett Levitan, Jürgen Kübler, Esther de Bekker-Grob & Isabelle Huys. (2019) Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discovery Today 24:1, pages 57-68.
Crossref